Search / Trial NCT06616454

The Effect of Time-Restricted Feeding on Body Composition and Some Metabolic Parameters in Obese Adolescents

Launched by SÜMEYRA BAŞAR · Sep 24, 2024

Trial Information

Current as of December 22, 2024

Not yet recruiting

Keywords

Pediatric Obesity Body Composition Healthy Diet Time Restricted Eating

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adolescents aged 12-18 with puberty stage:5
  • Obese adolescents with a metabolic disorder (such as fatty liver, insulin resistance, prediabetes, dyslipidemia) (BMI≥95th percentile for age)
  • Those who have a stable body weight for 3 months before the start of the study (current weight gain or loss \<4 kg)
  • Those who own and can use a Smartphone with Apple iOS or Android operating system
  • Those who speak, read and understand Turkish
  • Exclusion Criteria:
  • Those with any endocrine disorder, metabolic, chronic or major psychiatric disease other than obesity, insulin resistance, dyslipidemia, prediabetes, fatty liver
  • Polycystic ovary syndrome (PCOS)
  • Those with physical or mental disabilities
  • Those with allergies, intolerances or eating disorders
  • Those who smoke and drink alcohol
  • Use of drugs that may affect study results, circadian rhythms or metabolism (such as antidiabetics, steroids, beta blockers, adrenergic stimulating agents, laxatives, etc.)

Trial Officials

Sümeyra Başar

Study Director

sumeyra_akalin@hotmail.com

About Sümeyra Başar

Sümeyra Başar is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative study designs and rigorous methodologies. With a focus on transparency and ethical standards, Sümeyra Başar collaborates with healthcare professionals and research institutions to facilitate the development of cutting-edge therapies. The organization prioritizes patient safety and data integrity, ensuring that all clinical trials are conducted in compliance with regulatory requirements. Through its strategic initiatives, Sümeyra Başar aims to contribute significantly to the scientific community and improve health outcomes globally.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0